about
Recent advances in the understanding and management of IgA nephropathyThe genetics and immunobiology of IgA nephropathy.Genetic studies of IgA nephropathy: past, present, and future.Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease.UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohort.The coincidence of IgA nephropathy and Fabry diseaseGenetic contribution and associated pathophysiology in end-stage renal diseaseAsian leadership in chronic kidney disease.Continental variations in IgA nephropathy among AsiansIgA nephropathy in India: what we do know.Role of testosterone in the pathogenesis, progression, prognosis and comorbidity of men with chronic kidney disease.Pathology of IgA nephropathy.Polymorphisms of the COL1A2, CYP1A1 and HS1,2 Ig enhancer genes in the Tuaregs from Libya.IgA1 Glycosylation Is Heritable in Healthy Twins.IgA nephropathy: a twenty year retrospective single center experience.Immunoglobulin enhancer HS1,2 polymorphism: a new powerful anthropogenetic marker.Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents.Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort
P2860
Q26766126-8B0AE145-34AB-48EE-B65B-55FF46183E6CQ33872517-05A31064-B8E9-4992-B9D1-C66E188D7712Q34109845-6E88A1C1-A2F3-4C03-8280-8E4AF0DC1965Q34405441-15F42E19-F590-4949-AD60-228C7BBF5E8CQ34457527-E54D126C-7715-4259-9F2D-6B6C3CE9CA01Q34538744-188BB18B-B275-4A4D-A9D8-E91EE8FA6ECDQ34543669-B1B43236-1735-4069-92E1-CD59EC15DDB9Q36925161-BAE7C36A-01D6-408D-BBB2-1DD4FD215BE1Q37078194-EB0998F5-5136-4FD6-9B3C-A8C21B8DD499Q37108501-FC8DB67C-5D7C-42A0-9480-46203403FED8Q37827152-4357A638-0255-4840-B53E-1DDCD55C965CQ38151985-80EFE51D-02B8-4FB9-95B6-8DDA5AE5375EQ38214812-5A277C84-17FD-435D-8E51-54A009B17109Q39219594-D763FA61-5EDC-4340-A299-E28294AE0701Q39676321-80A47010-5E1C-44DB-AB64-203D614C55DFQ42145187-98808F22-106A-4360-9988-7CBAB2117B52Q46792904-20DEEC2F-97E9-4697-A7F2-DC7F47EFE72DQ47592540-F2D6E5EF-62AF-4554-ABA0-2C76A56C6982Q57824767-5D768D91-4B3A-46CA-B565-6EBFBE75C6BE
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Race/ethnicity and disease severity in IgA nephropathy
@ast
Race/ethnicity and disease severity in IgA nephropathy
@en
Race/ethnicity and disease severity in IgA nephropathy
@nl
type
label
Race/ethnicity and disease severity in IgA nephropathy
@ast
Race/ethnicity and disease severity in IgA nephropathy
@en
Race/ethnicity and disease severity in IgA nephropathy
@nl
prefLabel
Race/ethnicity and disease severity in IgA nephropathy
@ast
Race/ethnicity and disease severity in IgA nephropathy
@en
Race/ethnicity and disease severity in IgA nephropathy
@nl
P2093
P2860
P356
P1433
P1476
Race/ethnicity and disease severity in IgA nephropathy
@en
P2093
Eloisa F Fuentes
Glenn M Chertow
Jean L Olson
Yoshio N Hall
P2860
P2888
P356
10.1186/1471-2369-5-10
P407
P577
2004-09-02T00:00:00Z
P5875
P6179
1004322363